D.E. Shaw & Co
ARGS

D.E. Shaw & Co’s Argos Therapeutics, Inc. ARGS Stock Holding History

D.E. Shaw & Co’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,995
Closed -$196K – 2777
2016
Q4 		$196K Buy
+1,995
New +$196K ﹤0.01% 2343